Skip to content

DR.DRIJKONINGEN MARK

Active
Private limited companyfounded 2010active for 16 yearsKattenberg 94, 2460 Kasterlee, BelgiumKBO/BCE: BE 0826.385.857
Summary

DR.DRIJKONINGEN MARK has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €62,599 and a net result of €230,474. Equity has been stable since 2018 (±0.8% per year). Its solvency ranks better than 22% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 27-05-2010 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.188.870.029 2460 Kasterlee, since 03-06-2010
Financial year end
31 December
Peppol
Reachable since 23-09-2025

Board and ownership

Board
Shareholders
  • Mark DRIJKONINGENannual accounts 2017

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€318,233
▲ 9.9%
Turnover
≈ €490,000
estimated
Profit
€230,474
▲ 8.7%
Equity
€62,599
▲ 0.8%
Total assets
€253,274
▼ 10.7%
  • 2025 accounts filed 27 days after the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €253,274Liquidity: current ratio 1.11, cash €119,683Figures for financial year 2025 (filed on 27-08-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 45% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 50+3
equity 24.7% of total assets
Liquidity 59+5
short-term debt 75.3% · cash 47.3%
Profitability 100=
return on assets 91.0%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026highest value 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.11 (1.11 in 2024), below the usual 1.5. Short-term debt is 75.3% and cash 47.3% of total assets. 75.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 23% of them on solvency, 36% on liquidity, 80% on profitability and 40% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €253,274
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.11, cash €119,683
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 27-08-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 20706 sector peers (2025).
NBB · sector comparison
Position among 20706 sector peers
Solvency
better than 22%
← weakest strongest →
raises risk · 2025 accounts filed 27 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
27 days late
2024
22 days late
2023
29 days late
2022
16 days late
2021
2 days late
2020
26 days late
2019
7 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 18 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 91% of companies in human healthsector median €60,150 · 20,693 companies €230,474 View
  • Positive: 8 profitable years in a rowprofit 2025: €230,474 8 years View

Recent changes

  1. · Gazette deed Reappointment: Mark DRIJKONINGEN (director)
  2. · Gazette deed Incorporation
All 13 events

Comparable companies

These companies have the same main activity as DR.DRIJKONINGEN MARK: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €242,000 and €290,000, founded between 2006 and 2014.

CompanyTotal assetsGross margin
DR.DRIJKONINGEN MARK Kasterlee€253,274€318,233
Dr.Peter HEINEN Sankt Vith€282,107€339,317
SOCIETE MEDICALE NACIMA KISMA Enghien€274,181€296,173
DR. MARC VAN CLEEMPUT Boechout€242,086€308,836
Dokter Monballyu Pieter Brasschaat€285,572€293,322
CHAMART-SONVEAUX Braine-le-Comte€290,271€317,598
DR. CHARLOTTE DEPUYDT, PNEUMOLOOG Brugge€257,221€270,299
Full comparison

Key facts about DR.DRIJKONINGEN MARK

What is the company number of DR.DRIJKONINGEN MARK?
The company number of DR.DRIJKONINGEN MARK is 0826.385.857. The VAT number is the same number with BE in front: BE 0826.385.857.
Where is DR.DRIJKONINGEN MARK based?
The registered office is at Kattenberg 94, 2460 Kasterlee.Company details
What does DR.DRIJKONINGEN MARK do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR.DRIJKONINGEN MARK?
The legal form of DR.DRIJKONINGEN MARK is Private limited company (BV).
When was DR.DRIJKONINGEN MARK founded?
DR.DRIJKONINGEN MARK was founded on 27-05-2010.
Is DR.DRIJKONINGEN MARK still active?
Yes, DR.DRIJKONINGEN MARK is an active enterprise in the KBO register.
What is the turnover of DR.DRIJKONINGEN MARK?
The turnover in financial year 2025 is ≈ €490,000. This figure is estimated from the gross margin of €318,233 and 36 comparable companies (NACE 862). It probably lies between €440,000 and €620,000.Financials
Is DR.DRIJKONINGEN MARK profitable?
In financial year 2025, DR.DRIJKONINGEN MARK made a profit of €230,474.
Where can I find the annual accounts of DR.DRIJKONINGEN MARK?
DR.DRIJKONINGEN MARK filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR.DRIJKONINGEN MARK due?
DR.DRIJKONINGEN MARK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.